Nanomaterial cell interactions: Are current in vitro tests reliable?

Nanomedicine

Volumn 6, Issue 5, 2011, Pages 837-847

  Hirsch, Cordula ^a   Roesslein, Matthias ^a   Krug, Harald F ^a   Wick, Peter ^a  

^a SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

Author keywords

in vitro; intelligent testing strategy; ITS; LOEL; lowest observable effect level; measurement uncertainty; nanomaterials; QMS; quality management system; reliability; statistical evaluation; validation

Indexed keywords

BROXURIDINE; NANOMATERIAL; PROPIDIUM IODIDE;

CELL ASSAY; CELL INTERACTION; DOSE RESPONSE; NANOTECHNOLOGY; NANOTOXICOLOGY; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS;

ANIMALS; CYTOLOGICAL TECHNIQUES; HUMANS; NANOSTRUCTURES; REPRODUCIBILITY OF RESULTS; TOXICITY TESTS; VALIDATION STUDIES AS TOPIC;

EID: 79960954623     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.88     Document Type: Review

References (36)

1. Hartung T. Toxicology for the twenty-first century. Nature 460(7252), 208-212 (2009).
2. Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch. Toxicol. 85(7), 723-731 (2011).
3. Diabate S, Mulhopt S, Paur HR, Krug HF. The response of a co-culture lung model to fine and ultrafine particles of incinerator fly ash at the air-liquid interface. Altern. Lab. Anim. 36(3), 285-298 (2008).
4. Mogel M, Kruger E, Krug HF, Seidel A. A new coculture-system of bronchial epithelial and endothelial cells as a model for studying ozone effects on airway tissue. Toxicol. Lett. 96-97, 25-32 (1998). (Pubitemid 28430293)
5. Wottrich R, Diabate S, Krug HF. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono-and co-culture. Int. J. Hyg. Environ. Health 207(4), 353-361 (2004). (Pubitemid 39222729)
6. Bhabra G, Sood A, Fisher B et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat. Nanotechnol. 4(12), 876-883 (2009).
7. Lehmann AD, Daum N, Bur M, Lehr CM, Gehr P, Rothen-Rutishauser BM. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur. J. Pharm. Biopharm. 77(3), 398-406 (2011).
8. Rothen-Rutishauser BM, Kiama SG, Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am. J. Respir. Cell Mol. Biol. 32(4), 281-289 (2005). (Pubitemid 40478303)
9. Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM et al. Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur. Respir. J. 32(5), 1184-1194 (2008).
10. Panigel M, Pascaud M, Brun JL. Radioangiographic study of circulation in the villi and intervillous space of isolated human placental cotyledon kept viable by perfusion. J. Physiol. (Paris) 59(1 Suppl.), 277 (1967).
11. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am. J. Obstet. Gynecol. 114(6), 822-828 (1972).
12. Wick P, Malek A, Manser P et al. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 118(3), 432-436 (2010).
13. Maynard AD. Nanotechnology: the next big thing, or much ado about nothing? Ann. Occup. Hyg. 51(1), 1-12 (2007). (Pubitemid 46096390)
14. Service RF. Nanotoxicology. Nanotechnology grows up. Science304(5678), 1732-1734 (2004).
15. Krug HF, Wick P. Nanotoxicology: an interdisciplinary challenge. Angew. Chem. Int. Ed. Engl. 50(6), 1260-1278 (2011).
16. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 41(11), 4158-4163 (2007). (Pubitemid 46903235)
17. Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 8(7), 543-557 (2009).
18. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA 105(38), 14265-14270 (2008).
19. Lynch I, Dawson KA. Protein-nanoparticle interactions. NanoToday 3, 40-47 (2008). (Pubitemid 351298587)
20. Cedervall T, Lynch I, Lindman S et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA 104(7), 2050-2055 (2007). (Pubitemid 46391350)
21. Monopoli MP, Bombelli FB, Dawson KA. Nanobiotechnology: nanoparticle coronas take shape. Nat. Nanotechnol. 6(1), 11-12 (2011).
22. Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P. The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 45(13), 2643-2648 (2007). (Pubitemid 47588185)
23. Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6(6), 1261-1268 (2006). (Pubitemid 44013492)
24. Hirsch C, Kaiser J-P, Wessling F et al. A novel comprehensive evaluation platform to assess nanoparticle toxicity in vitro. Journal of Physics: Conference Series. NanoSafe2010, Grenoble, France (2011) (In press).
25. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234(2), 222-235 (2009).
26. Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45, 1425-1432 (2007). (Pubitemid 46829030)
27. Doak SH, Griffiths SM, Manshian B et al. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24(4), 285-293 (2009).
28. Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P. C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays. Environ. Pollut. 157(4), 1134-1139 (2009).
29. Wick P, Manser P, Limbach LK et al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol. Lett. 168(2), 121-131 (2007). (Pubitemid 46054362)
30. Kaiser JP, Roesslein M, Buerki-Thurnherr T, Wick P. Carbon nanotubes - curse or blessing. Curr. Med. Chem. 18, 2115-2128 (2011).
31. Roebben GG, Ramirez-Garcia S, Hackley VA et al. Interlaboratory reproducibility of size and surface charge measurements on nanoparticles prior to biological impact assessment. J. Nanoparticle Res. 13, 2675-2687 (2011).
32. Honsa JD, Mcintyre DA. ISO 17025: practical benefits of implementing a quality system. J. AOAC Int. 86(5), 6 (2003).
33. Ritz C, Streibig JC. Bioassay analysis using R. J. Stat. Softw. 12(5), 1-22 (2005). (Pubitemid 40218001)
34. Warheit DB. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol. Sci. 101(2), 183-185 (2008).
35. Geys J, Nemery B, Hoet PHM. Assay conditions can influence the outcome of cytotoxicity tests of nanomaterials: better assay characterization is needed to compare studies. Toxicol. in vitro 24(2), 620-629 (2010).
36. Hartung T. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. J. Toxicol. Environ. Health B Crit. Rev. 13(2-4), 277-290 (2010).